A lung transplant may offer a survival advantage for carefully selected patients with advanced lung cancer confined to the lungs, according to a new study published in JAMA. The findings suggest that transplantation could become a treatment option for patients who have exhausted conventional therapies
The interesting event combined scientific learning, multidisciplinary discussions, technology updates, and professional networking, providing a platform for cancer specialists to exchange knowledge while also encouraging camaraderie beyond the clinical setting Onco Life Cancer Centre organised an exclusive Doctors' Scientific Evening, bringing together oncologists, surgeons, radiation specialists,
With one in every nine Indians estimated to face the risk of developing cancer during their lifetime, a Rajya Sabha Parliamentary Committee has invited suggestions from stakeholders to strengthen access to affordable cancer prevention, diagnosis and treatment. The initiative comes amid rising cancer cases in
Dr SUSHANTKUMAR IKHAR, Senior Medical Oncologist & Hematologist HCG Hospital Nagpur Immunotherapy is a drug used in the treatment of cancer. It is a new modality of treatment. immunotherapy is given intravenously (injection) usually at 2 or 3 weeks interval. Ipilimumab is the first immunotherapy approved for cancer treatment. there are several others drugs in this category for example Pembrolizumab, Nivolumab , Atezolizumab and Avelumab. Immunotherapy
Dr. Adithyakrishna Srirangaprasad, Associate Consultant – Medical Oncology, HCG Cancer Hospital, Double Road Unit, Bengaluru. Cancer treatment has undergone a remarkable transformation over the past decade. While the primary goal has always been to control the disease and improve survival, there is now an equally important
Western India real-world data highlights the role of integrated oncology care, genomics, and nutrition in improving cancer outcomes Mumbai, 2nd June 2026: M|O|C Cancer Care & Research Centre has announced that six of its research abstracts have been accepted for presentation at the American Society of
Dr Raj Nagarkar, Chief of Surgical Oncology and Robotic Surgery at HCG Manavata Cancer Centre, Nasik Cancer often arrives like an unexpected storm, but for many people, its earliest signs can be surprisingly subtle, sometimes as simple as a change in the colour of urine. Bladder cancer, though
Revenue for Q3FY25 of INR 5,586 Million, a growth of 19% (y-o-y); 9MFY25 revenue stood at INR 16,377 Million, a growth of 16% (y-o-y) EBITDA for Q3FY25 of INR 923 Million, a growth of 15% (y-o-y) with 16.5% Margins and PAT for Q3FY25 of INR 70
Mankind Pharma Limited (BSE: 543904 | NSE: MANKIND) and Innovent Biologics have announced a groundbreaking partnership to exclusively license and commercialize sintilimab, an advanced PD-1 immunotherapy, in the Indian market. This strategic collaboration aims to address the critical challenges in cancer treatment and improve patient
Dr Nikhil Mehta, Consultant Surgical Oncologist, HCG Cancer Centre, Jaipur Colon cancer, traditionally considered a condition affecting older adults, has been increasingly diagnosed in younger individuals. According to the American Cancer Society, cases among adults under 50 have been steadily rising, making it critical for younger
